Characterization of Ovarian Masses Unable to Classify With Gynecological Ultrasonography: Value of Pelvic MRI With Perfusion- and Diffusion-weighted Imaging
Recruiting
Observational Study
Undetermined Ovarian Mass
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Female
- Study type
- Observational
- Participants needed
- 74 (estimated)
- Sponsor
- Universitaire Ziekenhuizen KU Leuven · Other
Who this trial is looking for
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of the study is to prospectively evaluate the value of pelvic MRI including diffusion- and perfusion-weighted sequences in the selected group of patients that have an undetermined ovarian mass at ultrasound.
Trial Locations
Loading…
Loading trial locations…
| Facility |
City |
State |
Country |
Status |
Eligibility Criteria
Inclusion Criteria:
\*Any woman with an adnexal mass undetermined by gynecological ultrasound
Exclusion Criteria:
* Any lesion with definite diagnosis by gynecological ultrasound
* Denial or withdrawal of oral informed consent.
* Contra-indication for MRI
Inclusion Criteria:
\*Any woman with an adnexal mass undetermined by gynecological ultrasound
Exclusion Criteria:
* Any lesion with definite diagnosis by gynecological ultrasound
* Denial or withdrawal of oral informed consent.
* Contra-indication for MRI
Contacts
No contact information available.